| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b5d728d4890268356fcc07e6e53840c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate |
2006-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62458bb062c404c65f74410c23f157d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aabba7c3bb729162d2eb7d4dea3d1a38 |
| publicationDate |
2007-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20070121758-A |
| titleOfInvention |
Injectable Compositions of Nanoparticulate Immunosuppressive Compounds |
| abstract |
The present invention relates to injectable nanoparticulate immunosuppressive compositions for the formation of subcutaneous or intramuscular reservoirs. The invention also relates to an injectable composition of nanoparticulate tacrolimus and / or sirolimus that eliminates the need to use polyoxy 60 hydrogenated castor oil (HCO-60) and / or polysorbate 80 as solubilizer. will be. In addition, the present invention discloses a method for preparing injectable nanoparticulate tacrolimus and / or sirolimus compositions, and includes subcutaneous or intramuscular storage for the prevention of organ rejection and for the treatment of psoriasis or other immune diseases. To an injectable nanoparticulate formulation comprising tacrolimus, sirolimus, or a combination thereof for the treatment. |
| priorityDate |
2005-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |